Abstract
Aims
To report the outcomes of the use of intracameral bevacizumab for iris neovascularization occurring after silicone oil (SO) removal in eyes undergoing vitreoretinal surgery (VRS).
Material and Methods
This study included 12 eyes that had iris neovascularization after SO removal. The clinical outcomes of 12 eyes after intravitreal bevacizumab injection were reviewed.
Results
There were eight men and four women with an average age of 41.58±12.68 years. All eyes had VRS for various vitreoretinal diseases. After the mean follow-up period of 9.7±5.3 months, SO removal was performed. Then, the patients were followed for more than 2 months and detailed retinal examinations and intraocular pressure (IOP) were normal during this period, but rubeosis iridis (RI) developed. RI was treated with 1 dose of 1.25 mg bevacizumab into the anterior chamber. After a mean follow-up period of 4.8±2.2 months, the regression of iris neovacularization was detected and IOP was below 21 mmHg in all eyes.
Conclusion
Anterior segment neovascularization (ASNV) may develop through various mechanisms in patients with VRS after SO removal, and anterior chamber injection of bevacizumab may lead to regression of ASNV.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Comaratta MR, Chang S, Sparrow J . Iris neovascularization in proliferative vitreoretinopathy. Ophthalmology 1992; 99: 898–905.
Cohen S, Kremer I, Yassur Y, Ben-Sira I . Peripheral retinal neovascularization and rubeosis iridis after a bilateral circular buckling operation. Ann Ophthalmol 1988; 20: 153–156.
Barile GR, Chang S, Horowitz JD, Reppucci VS, Schiff WM, Wong DT . Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery. Am J Ophthalmol 1998; 126: 379–389.
Oldendoerp J, Spitznas M . Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus. Graefes Arch Clin Exp Ophthalmol 1989; 227: 1–8.
Wand M, Madigan JC, Gaudio AR, Sorokanich S . Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy. Ophthalmic Surg 1990; 21: 113–118.
Falavarjani KG, Modarres M, Nazari H . Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye 2009. e-pub ahead of print 1 May 2009. doi:10.1038/eye.2009.94.
Ferrara N, Hillan KJ, Novotny W . Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 2005; 333: 328–335.
Lynch SS, Cheng CM . Bevacizumab for neovascular ocular diseases. Ann Pharmacother 2007; 41: 614–625.
Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006; 142: 158–160.
Qureshi K, Kashani S, Kelly SP . Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion. Int Ophthalmol 2008. E-pub ahead of print 14 September 2008.
McCuen 2nd BW, Rinkoff JS . Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy. Arch Ophthalmol 1989; 107: 677–682.
Federman JL, Schubert HD . Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988; 95: 870–876.
Brourman ND, Blumenkranz MS, Cox MS, Trese MT . Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology 1989; 96: 759–764.
Azzolini C, Brancato R, Camesasca FI, Codenotti M . Influence of silicone oil on iris microangiopathy in diabetic vitrectomized eyes. Ophthalmology 1993; 100: 1152–1158.
Peyman GA, Raichand M, Juarez CP, Reinglass S, John E . Hypotony and experimental rubeosis iridis in primate eyes. A clinicopathologic study. Graefes Arch Clin Exp Ophthalmol 1986; 224: 435–442.
Barr CC, Lai MY, Lean JS, Linton KL, Trese M, Abrams G et al. Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 1993; 100: 1629–1635.
Burk LL, Shields MB, Proia AD, McCuen 2nd BW . Intraocular pressure following intravitreal silicone oil injection. Ophthalmic Surg 1988; 19: 565–569.
Holland PM, Smith TR . Broad scleral buckle in the management of retinal detachments with giant tears. Am J Ophthalmol 1977; 83: 518–525.
Haut J, Larricart P, van Effenterre G . Localized retinectomy indications in the treatment and prevention of retinal detachment. Ophthalmologica 1984; 188: 212–215.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Batman, C., Ozdamar, Y. The effect of bevacizumab for anterior segment neovascularization after silicone oil removal in eyes with previous vitreoretinal surgery. Eye 24, 1243–1246 (2010). https://doi.org/10.1038/eye.2009.304
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2009.304
Keywords
This article is cited by
-
Mutations at Tyrosine 88, Lysine 92 and Tyrosine 470 of Human Dopamine Transporter Result in an Attenuation of HIV-1 Tat-Induced Inhibition of Dopamine Transport
Journal of Neuroimmune Pharmacology (2015)
